Bioasis Technologies Inc logo

Bioasis Technologies Inc

$ 0.13 +0.00202 (+1.62%) 10:08 PM EST
On watch
P/E:
At Loss
P/B:
0
Market Cap:
$ 9.32M
Enterprise V:
$ 9.66M
Volume:
7.17K
Avg Vol (2M):
14.76K
Also Trade In:
Volume:
7.17K
Market Cap $:
9.32M
PE Ratio:
At Loss
Avg Vol (2-Month):
14.76K
Enterprise Value $:
9.66M
PB Ratio:
0
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.
Name Current Vs Industry Vs History
Cash-To-Debt 0.43
Equity-to-Asset -1.66
Debt-to-Equity -0.83
Debt-to-EBITDA -0.59
Piotroski F-Score 0/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -48.53
Distress
Grey
Safe
Beneish M-Score 357.44
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 65.46
9-Day RSI 50.74
14-Day RSI 49.05
6-1 Month Momentum % -26.37
12-1 Month Momentum % -39.17

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.38
Quick Ratio 0.38
Cash Ratio 0.25
Days Sales Outstanding 816.45

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.6

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 155.94
EV-to-EBIT -4.4
EV-to-EBITDA -4.48
EV-to-Revenue 352.36
EV-to-FCF -3.78
Earnings Yield (Greenblatt) % -22.76

Financials

BIOAF's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:BIOAF

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.03
EPS (TTM) ($) -0.034
Beta 0.59
Volatility % 38.29
14-Day RSI 49.05
14-Day ATR ($) 0.008476
20-Day SMA ($) 0.13474
12-1 Month Momentum % -39.17
52-Week Range ($) 0.0972 - 0.2839
Shares Outstanding (Mil) 79.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bioasis Technologies Inc Filings

Document Form Filing Date
No Filing Data

Bioasis Technologies Inc Analysis

Share your research

Headlines

See More
No news.